Article
Molecular therapeutics of HBV.
Current gene therapy - 1 Aug 2003
Xu Ruian, Cai Kexia, Zheng Dexian, Ma Hong, Xu Sue, Fan Sheung-Tat
Abstract excerpt
The hepatitis B virus (HBV) infection is a public health problem worldwide, particularly in East Asia. The current therapy of HBV infection is mostly based on chemical agents and cytokines that have been shown to provide limited efficacy and are also toxic to the human body. Gene therapy is a new therapeutic strategy against HBV infection, involving the transmission of gene drugs into liver cells by specific...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
